Tag archive for ‘Celebrex’
Globes On Wednesday, December 17th, 2014

US court delays Teva launch of generic Celebrex

– Teva has lost its 180 days exclusivity for the generic version of Pfizer’s arthritis and chronic pain treatment. –   The US Supreme Court of Appeal Court of Appeals has overturned the More...

Shiri Habib-Valdhorn On Thursday, December 11th, 2014

Teva 2015 guidance sees falling revenue, stable profit

– Generic competition for Copaxone and foreign currency volatility will hit Teva’s sales. –   When Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) published its forecast for More...

Jewish Business News On Thursday, April 17th, 2014

Teva Settles Patent Litigation with Pfizer on arthritis treatment Celebrex

– Brand Celebrex has $2.2 billion in US sales in 2013, according to IMS data. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that its subsidiary Teva Pharmaceuticals USA, Inc. has More...

Wordpress site Developed by Fixing WordPress Problems